Bottom line
What is BRXVX's expense ratio?
BRXVX's expense ratio is 0.44%, or about $44 a year on every $10,000 invested. That is cheaper than 86% of international stock funds we track (median 0.9%). It has no front-end sales load.
Updated Dec 29, 2025
BRXVX fee table
| Net expense ratio | 0.44% |
|---|---|
| Gross expense ratio | 0.45% |
| Management fee | 0.35% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.1% |
| Fee waiver / reimbursement | -0.01% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Dec 29, 2025
What BRXVX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BRXVX | $45 | $143 | $251 | $566 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.44% expense ratio costs roughly $25,600 in lost growth, versus about $50,300 for the median international stock fund (0.9%).